Synthetic method of doxylamine succinate
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 珠海市海瑞德生物科技有限公司
- Publication Date
- 2017-08-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical fields of medical technology and organic synthesis, and in particular relates to a synthesis method of doxylamine succinate, an ethanolamine antihistamine. Background technique
[0002] Doxylamine succinate is a kind of ethanolamine drug, which has antihistamine effect, anticholinergic effect and significant sedative effect. It has strong activity and low gastrointestinal side effects, and is suitable for a variety of allergic skin diseases. Hay fever, allergic rhinitis, asthmatic bronchitis, etc., doxylamine succinate is a non-psychotropic, non-regulated over-the-counter drug. In October 1978, the FDA approved the marketing of doxylamine 25mg tablets from CHATTEM, which is used to help Relieve difficulty in falling asleep, became OTC in 1979, approved in September 1996 and approved the listing of generic drugs of LNK Company in August 2004. On April 8, 2013, the FDA approved Diclegis (doxylamine succinate and py...